Turkish Journal of Medical Sciences
Volume 31

Number 2

Article 12

1-1-2001

Distribution of Some Extracellular Matrix Proteins and
Ultrastructural Findings in Sural Nerve Biopsy in Demyelinating
Disease
EGEMEN İDİMAN
GÖKSEMİN DEMİR
Ü. ALİ KAYIŞLI
İ. Ş. ŞENGÜN
NECDET DEMİR

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
İDİMAN, EGEMEN; DEMİR, GÖKSEMİN; KAYIŞLI, Ü. ALİ; ŞENGÜN, İ. Ş.; DEMİR, NECDET; and DEMİR,
RAMAZAN (2001) "Distribution of Some Extracellular Matrix Proteins and Ultrastructural Findings in Sural
Nerve Biopsy in Demyelinating Disease," Turkish Journal of Medical Sciences: Vol. 31: No. 2, Article 12.
Available at: https://journals.tubitak.gov.tr/medical/vol31/iss2/12

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Distribution of Some Extracellular Matrix Proteins and Ultrastructural Findings in
Sural Nerve Biopsy in Demyelinating Disease
Authors
EGEMEN İDİMAN, GÖKSEMİN DEMİR, Ü. ALİ KAYIŞLI, İ. Ş. ŞENGÜN, NECDET DEMİR, and RAMAZAN
DEMİR

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol31/iss2/12

Turk J Med Sci
31 (2001) 155-161
© TÜB‹TAK
1

Egemen ‹D‹MAN
1
Göksemin DEM‹R
2
Ümit Ali KAYIfiLI
1
‹hsan fiükrü fiENGÜN
2
Necdet DEM‹R
2
Ramazan DEM‹R

Distribution of Some Extracellular Matrix Proteins
and Ultrastructural Findings in Sural Nerve Biopsy
in Demyelinating Disease

Received: February 03, 2000

Abstract: The involvement of both the
peripheral nervous system (PNS) and central
nervous system (CNS) in multiple sclerosis is a
seldom encountered combination in neurology
clinics. In this report, immunohistochemical
and ultrastructural techniques were used to
analyse the disease course of a patient
exhibiting involvement of both systems.
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In 1980, a 44-year-old man was admitted to
our clinic with progressive weakness and
decreased sensation of the right lower
extremity, and sensory abnormality exhibiting
stocking distribution. In electromyolography
(EMG), demyelinating sensory motor
polyneuropathy was determined. Ten years
later, he was admitted again due to
progression of weakness in the four
extremities. Pyramidal and cerebellar signs,
and loss of deep sensation were included in
the clinical picture. An EMG investigation
revealed severe segmental demyelination.
Hyperintense lesions were determined in the
periventricular deep white matter and the
corpus callosum using cranial magnetic
resonance imaging (MRI). This patient was
considered to be exhibiting a course of
demyelinating disease in which PNS and CNS

Introduction
Multiple sclerosis (MS) is generally known to be a
central nervous system (CNS) disease characterised by
dissemination of demyelinating plaques (1-3).
Abnormalities in peripheral nerves are rare observations
in MS and are frequently attributed to factors associated
with malnutrition, compression or cytotoxic drugs (4). In
a previous study, large amounts of abnormal teased
fibers and a reduction in myelin thickness were reported
(3). The authors suggested a possible alteration in the
peripheral myelin. Furthermore, extended demyelination,
onion-bulb formations in nerve roots, and the presence of
inflammatory cells have been found in some other studies
(1, 5-7). All of these data support the involvement of

were involved. In order to eliminate other
reasons for peripheral neuropathy (PN), a
sural nerve biopsy was carried out. The
expression of several extracellular matrix
(ECM) proteins (fibronectin, laminin, collagen
type-IV), their respective receptors (integrin
α5 and β4 subunits), intermediate filaments
(vimentin) and S-100 protein was
investigated
by
means
of
immunohistochemical methods. In addition,
peripheral nerve tissue samples were
evaluated ultrastructurally.
Immunohistochemical stainings revealed an
increase in the expression of ECM molecules,
such as fibronectin, laminin and collagen typeIV, and their respective receptors, α5 and β4.
This alteration might be a result of a
Schwann-axon
relationship.
Vimentin
expression was found to have changed in the
Schwann cells and S-100 immunoreactivity
decreased in the region near the Schwannaxon interface. Our ultrastructral findings
showed myelin fragmentation, axon
vacuolisation and degeneration.
Key Words: multiple sclerosis, sural nerve,
fibronectin, laminin, integrin α5 and β4
subunits

both the PNS and CNS in multiple sclerosis. It is known
that myelin structures exhibit a similar macromolecular
organisation in both systems, which leads to the
formation of closely related epitopes (8). This might be
the reason for some sort of a cross reactivity between the
PNS and CNS in some individuals (9-11).
Matrix metalloproteinases (MMPs) are highly
expressed during the course of the disease and are
frequently emphasised in the pathogenesis of MS (1214). Together with adhesion molecules, MMPs can be
responsible for the destruction of the extracellular matrix
(ECM) in the blood-brain barrier (12). As a result,
inflammatory mononuclear cells will migrate into the CNS
and damage the myelin structure (15-19). The same
155

Distribution of Some Extracellular Matrix Proteins and Ultrastructural Findings in Sural Nerve Biopsy in Demyelinating Disease

destructive proteolytic process can also be considered for
the involvement of the PNS in MS (20-22). In order to
shed light on this, we performed immunohistochemical
and ultrastructural analysis of a sural nerve biopsy from
a patient who exhibited CNS demyelination accompanied
with polyneuropathy in PNS. In the immunohistochemical
analysis, we evaluated the distribution of some ECM
proteins (laminin, collagen IV and fibronectin), their
adhesive receptors (integrin α5 subunit for fibronectin
and integrin β4 subunit for laminin and collagen),
intermediate filaments (vimentin) and adhesive molecules
(S100 protein). In the ultrastructural analysis, we studied
the fine structure organisation.
Materials and methods
Patient
A 44-year-old man was admitted to hospital in 1980
because of progressive weakness and decreased sensation
of the right lower extremity. In a routine neurologic
examination, a mild weakness was found in the right
lower extremity, accompanied by sensory abnormality in
stocking distribution. In an EMG investigation
demyelinating sensory motor polyneuropathy was
determined. The patient was recovered within a month,
but he was not aware of the nature of the treatment.
Ten years later, he was admitted again because of a
progression in weakness in the four extremities.
Pyramidal and cerebellar signs and loss of deep sensation
were added to the clinical picture in neurologic
examination. An EMG investigation revealed severe
segmental demyelination. In cranial MRI, hyperintense
lesions were determined in the periventricular deep white
matter and the corpus callosum. He was treated with
intravenous methylprednisolone and the patient suffered
no more complaints.
During the previous 10 years the complaints of the
patient slowly progressed. In his last visit to our clinic,
prominent mild tetraparesis in the right half of the body,
sensory abnormalities in stocking distribution, severely
diminished vibration and position sense, bilateral
cerebellar signs, and atrophy in the tenar, hypotenar,
interosseus, pectoral and deltoid muscles were
determined.
The last EMG revealed severe segmental
demyelination with mild partial axonal degeneration,
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where the sensory component was totally involved. In
cranial MRI, a relatively diffuse increase in demyelinating
plaques was observed bilaterally. These plaques were
vertically localised to the septocallosal margin in the
periventricular deep white matter.
Immunohistochemistry
A sural nerve biopsy was carried out and 5µmsections from paraformaldehyde fixed and paraffin
embedded material were prepared. These sections were
used for immunohistochemical localisation.
The sections were deparaffinised and then immersed
in methanol containing 3 % H2O2 so as to block
endogenous peroxidase activity (37ºC, 10 minutes). Then
the sections were washed with phosphate-buffered saline
(PBS, 10mM, pH, 7.2) at room temperature for 30
minutes. After the blocking of non-specific binding with
normal multispecies serum at 37ºC for 20 minutes, the
sections were incubated with primary monoclonal
antibodies against laminin (1/50 dilution), collagen type
IV (1/50 dilution), fibronectin (1/1500 dilution), integrin
β4 (1/1000 dilution), integrin α5 (1/1000 dilution),
vimentin (1/100 dilution) and S 100 (1/100 dilution).
After incubation at 37ºC for 60 minutes, the sections
were washed with PBS and incubated with biotin-bound
goat anti-mouse IgG antibody (37ºC, 30 minutes).
Following several washing steps with PBS, the sections
were incubated with horseradish peroxidase conjugated
to streptavidine (37ºC, 30 minutes). The immunostaining
was developed with 3,3-diaminobenzidine chromogen at
room temperature for 10 minutes. The sections were
counterstained with hematoxylene, mounted with cover
slips and examined under a light microscope.
Ultrastructural analysis
The sural nerve biopsy samples were fixed by
immersion in 2.5% glutaraldehyde in 0.1 M cacodylate
buffer (pH 7.4) at room temperature for 4 hours and
postfixed in 1% phosphate-buffered osmium tetroxide
for 2 hours. The samples were dehydrated in an
ascending ethanol series and were embedded in araldyteepoxy resin. Semithin and ultrathin sections were taken
with an ultratome. After staining with uranyl acetate and
lead citrate, the sections were examined with a Jeol 100
C electron microscope.
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Results
Immunoreactivities for laminin and integrin β4
subunit were observed in the basal lamina of both
Schwann cells and vessel wall components. The cytoplasm
of connective tissue cells, which were distributed around
peripheral nerve bundles, were not immunoreactive for
laminin or integrin receptor β4. However, the
perineurium and endoneurium were immunoreactive for
these antibodies (Figures 1a, b). The staining for collagen
type IV was similar to that for laminin (Figure 1c). The
immunoreactivities obtained by antibodies against
fibronectin and integrin α5 subunit were abundant in the
Schwann cells, but the stroma was very weakly reactive
(Figures 2a, b).
In some segments of the sural nerve, the Schwann
cells exhibited an increase in vimentin expression,
whereas in some segments preserving axon-Schwann
contact, vimentin immunoreactivity was weak. The
intensity of vimentin immunoreactivity decreased as long
as the relationship between the Schwann cells and axons
continued (Figure 7). The connective tissue cells in the
epineurium were also strongly immunoreactive with
vimentin antibody.
S100 immunoreactivity decreased in the contact areas
between the Schwann cells and axons of the sural nerve.
Both
structures
demonstrated
heterogeneous
immunoreactivity in different nerve segments (Figure 8).
Electron microscopic analysis of the sural nerve biopsy
revealed myelin fragmentation, referred to as onion-bulb
neuropathy, in different configurations and with different
diameters. The presence of segmental demyelination and
the proliferation of Schwann cells in a concentrated
manner were determined. In addition, many onion bulbs,
collateral myelin figures and numerous regenerative
myelin clusters were observed. In contrast to active
demyelination, the Schwann cells exhibited striking
degeneration (Figures 3-6).
Figures 1a-c.

Discussion
MS is characterised by demyelinated areas spread
throughout the central nervous system (CNS). Although it
is very rare, PNS involvement can accompany classical
CNS disease. In this study, we demonstrated the presence
of a remarkable relationship between the peripheral
neuropathy and CNS demyelinisation. In the literature,

The normal intensity of immunoreactivity of laminin (a)
and its receptor integrin β4 subunit (b) can be seen in
the sural nerve section when compared with the
peripheral connective tissue components. The intensity
of collagen type VI (c) immunoreactivity is weak as the
laminin staining and its immunoreactivity is low
compared to the perivascular tissue. Original
magnification, X50.

the presence of peripheral neuropathy together with
central demyelinisation has been reported in only a few
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Figures 2a and 2b.

Figure 3.

Fibronectin (a) and its receptor integrin α5 subunit (b) can be seen in these micrographs. Strong staining may be detected in some
Schwann cells (SC), dependent upon their affinity to the antibody (single arrows). Original magnifications, a:X50, b:X100.

A topographic view of the sural nerve can be seen in this
electronmicrograph. Severe structural degeneration,
Schwann cell proliferation and also degeneration and
onion-bulb formation (single arrows) are striking results.
There is tructural degeneration and fragmentation in the
myelin sheaths (M), myelin remnants (double arrows) in
degenerated Schwann cells (DSC), and increased colloidal
substance (Col) between the Schwann cells and
endoneurium. Original magnification, X5000.

cases (1, 5, 9, 10). Ro et al. (1) observed hypertrophic
changes in a sural nerve biopsy from a patient having a
clinical background for MS. In other research, in addition
to hypertrophic degeneration, focal demyelination and
mononuclear infiltration in the peripheral nerve tissue of
MS patients reported (7, 23). However, Pollock et al. (6)
suggested
that
neither
demyelinisation
nor
remyelinisation is associated with PNS in MS patients.
In the present study, immunohistochemistry and
electron microscopy revealed alterations in the expression
of different sural nerve components. Increase in
158

Figure 4.

In this electronmicrograph, a Schwann cell (SC) with a
heterochromatic nucleus (N), colloidal oedema (Col) and
myelin fragments (M) in its cytoplasm can be observed.
Original magnification, X8000.

immunoreactivities for fibronectin, integrin α5 subunit
and vimentin suggest ongoing Schwann cell
differentiation and migration in several segments of the
peripheral nerve. It has been suggested that fibronectin
and its receptor play a role in the pathophysiology of
inflammation during tissue remodelling (24). In a
previous study, the relationship between the ECM
(fibronectin and laminin) and neurophilic reaction
(astrocytes, macrophages and microglia) in the sural
nerve biopsy of a patient with central demyelinating
disease was discussed (25). Furthermore, a high number
of macrophages and microglia have been observed in the
CNS of MS patients, dependent upon the occurrence of
lesions (25, 26). Blakemore and Crang (27) suggested
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Figure 5.

High magnification of onion-bulb formations in the sural
nerve in the MS patient. Degenerated areas between the
axon and Schwann cells (SC) at opposite faces including the
myelin (M) sheath and axsolemma can be seen. Original
magnification, X12.000.

Figure 6.

Degenerated segmental nerve bundle that is supported and
limited by connective tissue of the endoneurium. The
formation of collateral myelin infoldings (single arrows) on
the Schwann cell (SC) and vacuolisation (V) in axoplasma
and remyelination in the SC are interesting findings.
Original magnification, X12000.

that the cells in the lesion site could influence the extent
of Schwann cell remyelination. However, the presence of
the ECM seems to be the main factor influencing Schwann
cell remyelination (12, 25).
In our study, we observed heterogenous stainings for
S100 protein. Together with the alterations in the
expression of several ECMs, this finding suggests loss of
contact between Schwann cells and axons. Our
ultrastructural observations also demonstrate that onion
bulbs are formed, and that by means of collateral

Figure 7.

Vimentin immunoreactivity is very strong in the transverse
section of the sural nerve in the MS patient. According to
the Schwann cell (SC) proliferation and remyelination in the
segmental area, the vimentin immunoreactivity is
increased. In the perineurium and in the vascular wall,
strong vimentin immunoreactivity is present. Original
magnification, X50.

Figure 8.

This micrograph shows S100 protein expression in a
Schwann cell (SC). A heterogenous immunoreaction for
S100 protein can be observed. Original magnification,
X50.

segments, demyelination and remyelination take place.
On the basis of these findings, it seems that there is a
very active matrix reorganisation in the sural nerve. The
family of matrix metalloproteinases (MMPs) might play
an important role in this reorganisation. These enzymes
are known to degrade the components of the ECM in
many tissues (12). Their degradative effect was also
described in vascular basement membrane, permitting
leukocyte migration into inflammation sites (12, 17).
Vitronectin and its integrin receptor in particular have
multiple functions in demyelinating lesions, such as in
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clotting and leukocyte extravasation (16, 21, 22). In CNS
lesions in MS, the presence of inflammatory cells
expressing MMPs has been reported (16, 22, 26, 28).
Therefore, these molecules might contribute to the tissue
destruction and matrix remodelling in PNS and CNS.
We can conclude from our results that alterations in
the PNS accompany to the demyelinisation of the CNS.
These alterations include altered expression of the ECM
(fibronectin), ECM receptors (integrin α5 subunit),
intermediate filaments (vimentin) and adhesion molecules
(S100 protein). In addition to this matrix reorganisation,
peripheral conduction is impaired due to myelin damage
and fragmentation, axonal vacuolisation, degeneration of
Schwann cells, accumulation of extracellular fluid and
segmental edema. We believe that the progression in the
complaints of the 44-year-old patient is closely related to
these pathophysiological changes. The clinical course of
this patient is dependent upon the severity of

immunological attack as well as the other causes in both
the PNS and CNS. This will most probably result in an
increase in MMP expression, turnover and reorganisation
of the ECM, activation and proliferation of Schwann cells
and degeneration of myelin sheaths. Future studies that
make use of advanced immunological and molecular
methods should answer the question of whether these
two entities share common etiologic factors and
pathophysiological pathways.
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